USA |OTCQB |USD
|Public Float||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||18.66%||Ex-Dividend Date|
|Held by Institutions||3.01%||IPO Date||-|
|Dec 20||Dec 19||Dec 18|
|Sep 21||Jun 21||Mar 21|
Acura pharmaceuticals trades on the OTC Markets stock market in USA under the ticker symbol "ACUR". Acura pharmaceuticals’s stock symbol can also be displayed as "OTCMKTS:ACUR".
Acura pharmaceuticals (OTCMKTS:ACUR) is owned by 3.01% institutional shareholders and by 18.66% insiders. The rest is owned by the public.
Explore More Details on Acura pharmaceuticals's “Ownership” Section
Acura pharmaceuticals's key executive team includes the following managers:
Acura pharmaceuticals (OTCMKTS:ACUR) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.
Currently the number of employees working for Acura pharmaceuticals is 12.
Acura pharmaceuticals (OTCMKTS:ACUR) is headquartered in IL, United States.
Acura pharmaceuticals’s mailing address is 616 N. North Court, Palatine, IL, United States, 60067.
The company’s phone number is 847 705 7709.